Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term carriers. Found 14 abstracts

Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benitez J, Garcia MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans G, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ES, Lazaro C, Blanco I, Montagna M, D'Andrea E, Nicoletto MO, Johnatty SE, Kruger S, Jensen A, Hogdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song HL, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg A, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PD. Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer. JAMA-Journal of the American Medical Association. 2012 Jan;307(4):382-90.
Thompson HS, Sussner K, Schwartz MD, Edwards T, Forman A, Jandorf L, Brown K, Bovbjerg DH, Valdimarsdottir HB. Receipt of Genetic Counseling Recommendations Among Black Women at High Risk for BRCA Mutations. Genetic testing and molecular biomarkers. 2012 Nov;16(11):1257-62.   PMCID: not NIH funded
Han ZY, Nogusa S, Nicolas E, Balachandran S, Taylor J. Interferon Impedes an Early Step of Hepatitis Delta Virus Infection. PLoS One. 2011 Jul;6(7):e22415.   PMCID: PMC3139649
Maxwell CA, Benitez J, Gomez-Baldo L, Osorio A, Bonifaci N, Fernandez-Ramires R, Costes SV, Guino E, Chen H, Evans GJ, Mohan P, Catala I, Petit A, Aguilar H, Villanueva A, Aytes A, Serra-Musach J, Rennert G, Lejbkowicz F, Peterlongo P, Manoukian S, Peissel B, Ripamonti CB, Bonanni B, Viel A, Allavena A, Bernard L, Radice P, Friedman E, Kaufman B, Laitman Y, Dubrovsky M, Milgrom R, Jakubowska A, Cybulski C, Gorski B, Jaworska K, Durda K, Sukiennicki G, Lubinski J, Shugart YY, Domchek SM, Letrero R, Weber BL, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE, Easton DF, Peock S, Cook M, Oliver C, Frost D, Harrington P, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Eccles D, Douglas F, Brewer C, Nevanlinna H, Heikkinen T, Couch FJ, Lindor NM, Wang XS, Godwin AK, Caligo MA, Lombardi G, Loman N, Karlsson P, Ehrencrona H, von Wachenfeldt A, Barkardottir RB, Hamann U, Rashid MU, Lasa A, Caldes T, Andres R, Schmitt M, Assmann V, Stevens K, Offit K, Curado J, Tilgner H, Guigo R, Aiza G, Brunet J, Castellsague J, Martrat G, Urruticoechea A, Blanco I, Tihomirova L, Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Deissler H, Varon-Mateeva R, Sutter C, Niederacher D, Imyamitov E, Sinilnikova OM, Stoppa-Lyonne D, Mazoyer S, Verny-Pierre C, Castera L, de Pauw A, Bignon YJ, Uhrhammer N, Peyrat JP, Vennin P, Ferrer SF, Collonge-Rame MA, Mortemousque I, Spurdle AB, Beesley J, Chen XQ, Healey S, Barcellos-Hoff MH, Vidal M, Gruber SB, Lazaro C, Capella G, McGuffog L, Nathanson KL, Antoniou AC, Chenevix-Trench G, Fleisch MC, Moreno V, Pujana MA. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. Plos Biology. 2011 Nov;9(11):e1001199.   PMCID: PMC3217025
Miller-Samuel S, McDonald DJ, Weitzel JN, Santiago F, Martino MA, Namey T, Augustyn A, Mueller R, Forman A, Bradbury AR, Morris GJ. Variants of Uncertain Significance in Breast Cancer-Related Genes: Real-World Implications for a Clinical Conundrum. Part One: Clinical Genetics Recommendations. Seminars in Oncology. 2011 Aug;38(4):469-80.   PMCID: not NIH funded
Nie H, Evans AA, London WT, Block TM, Ren XD. Ultrasensitive Quantification of Hepatitis B Virus A1762T/G1764A Mutant by a SimpleProbe PCR Using a Wild-Type-Selective PCR Blocker and a Primer-Blocker-Probe Partial-Overlap Approach. Journal of Clinical Microbiology. 2011 Jul;49(7):2440-8.   PMCID: PMC3147845
Schrader KA, Masciari S, Boyd N, Salamanca C, Senz J, Saunders DN, Yorida E, Maines-Bandiera S, Kaurah P, Tung N, Robson ME, Ryan PD, Olopade OI, Domchek SM, Ford J, Isaacs C, Brown P, Balmana J, Razzak AR, Miron P, Coffey K, Terry MB, John EM, Andrulis IL, Knight JA, O'Malley FP, Daly M, Bender P, Moore R, Southey MC, Hopper JL, Garber JE, Huntsman DG. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. Journal of Medical Genetics. 2011 Jan;48(1):64-8.   PMCID: PMC3003879
Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen XQ, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek SM, Nathanson KL, Pankratz VS, Lindor NM, Godwin AK, Caligo MA, Hopper J, Southey MC, Giles GG, Justenhoven C, Brauch H, Hamann U, Ko YD, Heikkinen T, Aaltonen K, Aittomaki K, Blomqvist C, Nevanlinna H, Hall P, Czene K, Liu JJ, Peock S, Cook M, Platte R, Evans DG, Lalloo F, Eeles R, Pichert G, Eccles D, Davidson R, Cole T, Cook J, Douglas F, Chu C, Hodgson S, Paterson J, Hogervorst FB, Rookus MA, Seynaeve C, Wijnen J, Vreeswijk M, Ligtenberg M, van der Luijt RB, van Os TA, Gille HJ, Blok MJ, Issacs C, Humphreys MK, McGuffog L, Healey S, Sinilnikova O, Antoniou AC, Easton DF, Chenevix-Trench G. No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Research and Treatment. 2009 Sep;117(2):371-9.   PMCID: PMC2728174
Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, Isaacs C, Olopade OI, Tomlinson G, Rubinstein WS, Tung N, Blum JL, Gillen DL. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Research. 2009 Jan;11(5).   PMCID: PMC2790858
Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Jul;296(2):185-92.
Rebbeck TR, Kantoff PN, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. American journal of human genetics. 1999 May;64(5):1371-7.
Liede A, Tonin PN, Sun CC, Serruya C, Daly MB, Narod SA, Foulkes WD. Is hereditary site-specific ovarian cancer a distinct genetic condition?. American Journal of Medical Genetics. 1998 Jan 06;75(1):55-8.
Lazinski DW, Taylor JM. Recent Developments in Hepatitis-Delta Virus Research. In: Advances in Virus Research, Vol 43. 1994. p. 187-231.
Unander DW, Webster GL, Blumberg BS. Usage and Bioassays in Phyllanthus (Euphorbiaceae) - a Compilation .3. The Subgenera Eriococcus, Conami, Gomphidium, Botryanthus, Xylophylla and Phyllanthodendron, and a Complete List of the Species Cited in the 3-Part Series. Journal of Ethnopharmacology. 1992 Apr;36(2):103-12.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term carriers

carriers risk ovarian-cancer breast-cancer family-history mutation infection disease gene susceptibility brca1 mammary-gland susceptibility gene mutations hepatitis-b virus system multiple-myeloma molecular-cloning antineoplastic agents amarus plants adherens junctions resource 2002 eeseman im-cell-v111-p163 breast-cancer risk hereditary ovarian cancer therapeutic target older transactivation cells b surface-antigen 1994 rd d-lancet-v343-p692 series factor-i ovarian carcinoma brca1 mutations guidelines penetrance diffuse gastric-cancer core-promoter polymerase 2007 ylor jm-p3031 brca1-dependent ubiquitination hbsag- site-specific ovarian cancer rna-polymerase multiethnic cohort traditional medicine tumors luminal cell fate binding protein-5 igfbp-5 single-nucleotide polymorphism brca2 genes families glycosides united-states Breast cancer GATA3-Polymorphism-BRCA1 and BRCA2-Risk population phyllanthus expression missense mutations p53 germline mutations genome replication circulating levels nuclear transport colorectal-cancer common variants frequency carcinoma entry density consortium african-american women unclassified increase BRCA1 b-virus low-grade protein progenitor-cell fate 1994 rd d-v343-p692 ethnobotany nonsense acuminatus vahl stem-cells carcinomatosis progesterone-receptor inhibitors bioassays e-antigen seroconversion prophylactic oophorectomy e-cadherin mutations sequence insights estrogen-receptor 1993 nair anb-v382-p161 catalytic rna message association mitotic spindle associations centrosomal microtubule nucleation differentiation replication mammographic adenomatous polyposis hepatocellular-carcinoma viral load variants antigen behaviors 185delAG prostate-cancer clinics leucine zipper
Last updated on Friday, December 06, 2019